Clonazoline
- CAS No.
- 17692-28-3
- Chemical Name:
- Clonazoline
- Synonyms
- Clonazoline;2-[(4-Chloro-1-naphtyl)methyl]-2-imidazoline;2-((4-Chloronaphthalen-1-yl)methyl)-4,5-dihydro-1H-imidazole;1H-Imidazole, 2-[(4-chloro-1-naphthalenyl)methyl]-4,5-dihydro-
- CBNumber:
- CB91116158
- Molecular Formula:
- C14H13ClN2
- Molecular Weight:
- 244.72
- MDL Number:
- MFCD00868470
- MOL File:
- 17692-28-3.mol
- MSDS File:
- SDS
Last updated:2026-05-28 04:53:39
| FDA UNII | YH9K692U9S |
|---|
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H335 |
| Precautionary statements | P264-P270-P301+P312-P330-P501 |
Clonazoline Preparation Products And Raw materials
Raw materials
Preparation Products
Clonazoline Suppliers
Global Suppliers ( 9)
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 29874 | 58 |
| Cato Research Chemicals Inc. | 81960175 18933936954 | 2853283383@qq.com | China | 11418 | 58 |
| Alchem Pharmtech,Inc. | 8485655694 | sales@alchempharmtech.com | United States | 63645 | 58 |
| TargetMol Chemicals Inc. | 13564774135 | marketing@targetmol.com | United States | 19950 | 58 |
| Supplier | Advantage |
|---|---|
| TargetMol Chemicals Inc. | 58 |
| Cato Research Chemicals Inc. | 58 |
| Alchem Pharmtech,Inc. | 58 |
| TargetMol Chemicals Inc. | 58 |
View Latest Price from Clonazoline manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-04-21 | Clonazoline
17692-28-3
|
$1520.00-2500.00 | 10g | TargetMol Chemicals Inc. |
-

- Clonazoline
17692-28-3
- $1520.00-2500.00
- TargetMol Chemicals Inc.
17692-28-3 (Clonazoline) Related Search:
Clonazoline
2-[(4-Chloro-1-naphtyl)methyl]-2-imidazoline
2-((4-Chloronaphthalen-1-yl)methyl)-4,5-dihydro-1H-imidazole
1H-Imidazole, 2-[(4-chloro-1-naphthalenyl)methyl]-4,5-dihydro-
17692-28-3
C14H13ClN2





